Yaping Xie

216 Huansha Road
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Shikonin suppresses diffuse large B-cell lymphoma progression by inducing ferritinophagy and ferroptosis via lncRNA ADPGK-AS1 downregulation.

Shikonin suppresses diffuse large B-cell lymphoma progression by inducing ferritinophagy and ferroptosis via lncRNA ADPGK-AS1 downregulation.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 15, 2026

Review Article: Drug-Induced Liver Injury Associated With Antibody-Based Therapies in Haematologic Malignancies.

Review Article: Drug-Induced Liver Injury Associated With Antibody-Based Therapies in Haematologic Malignancies.

Journal: Alimentary pharmacology & therapeutics
Published: February 28, 2025

Efficacy and safety of low-dose TBI combined MAC regimen for HSCT in high-risk AML patients with active disease.

Efficacy and safety of low-dose TBI combined MAC regimen for HSCT in high-risk AML patients with active disease.

Journal: Annals of medicine
Published: December 28, 2024

Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma.

Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma.

Journal: Blood advances
Published: December 02, 2024

Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.

Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.

Journal: Haematologica
Published: November 29, 2024

SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients.

SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients.

Journal: Apoptosis : an international journal on programmed cell death
Published: June 24, 2024

Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting.

Multifaceted role of GCN2 in tumor adaptation and therapeutic targeting.

Journal: Translational oncology
Published: May 31, 2024

Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma.

Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma.

Journal: Haematologica
Published: December 08, 2023

Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era.

Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era.

Journal: Hematology (Amsterdam, Netherlands)
Published: December 01, 2023

ST11 KPC-2-Producing Klebsiella pneumoniae Isolated from Patient with Acute Myelocytic Leukemia.

ST11 KPC-2-Producing Klebsiella pneumoniae Isolated from Patient with Acute Myelocytic Leukemia.

Journal: Infection and drug resistance
Published: October 11, 2023

A first case of successful using of ibrutinib in treating paraneoplastic pemphigus related bronchiolitis obliterans concurrent with CLL.

A first case of successful using of ibrutinib in treating paraneoplastic pemphigus related bronchiolitis obliterans concurrent with CLL.

Journal: Frontiers in medicine
Published: December 27, 2022

Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma.

Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma.

Journal: Scientific reports
Published: March 21, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026